Can thrombin-activated platelet releasate compensate the age-induced decrease in cell proliferation of MSC?

Journal of Orthopaedic Research

Volumn 31, Issue 11, 2013, Pages 1786-1795

  Vogl, Melanie ^a   Fischer, Johannes ^a   Jäger, Marcus ^b   Zilkens, Christoph ^a   Krauspe, Rüdiger ^a   Herten, Monika ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

age induced decrease; mesenchymal progenitor cells (MSC); platelet releasate (PR); platelet rich plasma (PRP); thrombin

Indexed keywords

PLATELET DERIVED GROWTH FACTOR; PLATELET RELEASATE; THROMBIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; AGING; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STIMULATION; CONCENTRATION (PARAMETERS); GROUPS BY AGE; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MESENCHYMAL STEM CELL; OSTEOBLAST; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; THROMBOCYTE POOR PLASMA; THROMBOCYTE RICH PLASMA;

AGE-INDUCED DECREASE; MESENCHYMAL PROGENITOR CELLS (MSC); PLATELET RELEASATE (PR); PLATELET-RICH PLASMA (PRP); THROMBIN;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ALKALINE PHOSPHATASE; BLOOD PLATELETS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; HUMANS; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; PLATELET ACTIVATION; THROMBIN;

EID: 84884901907     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.22433     Document Type: Article

References (44)

1. Bianco P, Riminucci M, Gronthos S, et al. 2001. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 19: 180-192.
2. Friedenstein AJ, Petrakova KV, Kurolesova AI, et al. 1968. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 6: 230-247.
3. Dominici M, Le Blanc K, Mueller I, et al. 2006. Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy 8: 315-317.
4. Rastegar F, Shenaq D, Huang J, et al. 2010. Shi Q and others. Mesenchymal stem cells: molecular characteristics and clinical applications. World J Stem Cells 2: 67-80.
5. Camargo PM, Lekovic V, Weinlaender M, et al. 2002. Platelet-rich plasma and bovine porous bone mineral combined with guided tissue regeneration in the treatment of intrabony defects in humans. J Periodontal Res 37: 300-306.
6. Garg AK,. 2000. The use of platelet-rich plasma to enhance the success of bone grafts around dental implants. Dent Implantol Update 11: 17-21.
7. Hakimi M, Jungbluth P, Sager M, et al. 2010. Combined use of platelet-rich plasma and autologous bone grafts in the treatment of long bone defects in mini-pigs. Injury 41: 717-723.
8. Alsousou J, Thompson M, Hulley P, et al. 2009. The biology of platelet-rich plasma and its application in trauma and orthopaedic surgery: a review of the literature. J Bone Joint Surg Br 91: 987-996.
9. Weibrich G, Buch RS, Kleis WK, et al. 2002. Quantification of thrombocyte growth factors in platelet concentrates produced by discontinuous cell separation. Growth Factors 20: 93-97.
10. Andrew JG, Hoyland JA, Freemont AJ, et al. 1995. Platelet-derived growth factor expression in normally healing human fractures. Bone 16: 455-460.
11. Bostrom MP,. 1998. Expression of bone morphogenetic proteins in fracture healing. Clin Orthop Relat Res 355: S116-S123.
12. Bourque WT, Gross M, Hall BK,. 1993. Expression of four growth factors during fracture repair. Int J Dev Biol 37: 573-579.
13. Joyce ME, Jingushi S, Bolander ME,. 1990. Transforming growth factor-beta in the regulation of fracture repair. Orthop Clin North Am 21: 199-209.
14. Zimmermann G, Henle P, Kusswetter M, et al. 2005. TGF-beta1 as a marker of delayed fracture healing. Bone 36: 779-785.
15. Kasten P, Vogel J, Geiger F, et al. 2008. The effect of platelet-rich plasma on healing in critical-size long-bone defects. Biomaterials 29: 3983-3992.
16. Bieback K, Hecker A, Kocaomer A, et al. 2009. Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. Stem Cells 27: 2331-2341.
17. Kocaoemer A, Kern S, Kluter H, et al. 2007. Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Stem Cells 25: 1270-1278.
18. Phinney DG, Kopen G, Righter W, et al. 1999. Donor variation in the growth properties and osteogenic potential of human marrow stromal cells. J Cell Biochem 75: 424-436.
19. Stolzing A, Jones E, McGonagle D, et al. 2008. Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies. Mech Ageing Dev 129: 163-173.
20. Leskela HV, Risteli J, Niskanen S, et al. 2003. Osteoblast recruitment from stem cells does not decrease by age at late adulthood. Biochem Biophys Res Commun 311: 1008-1013.
21. Roura S, Farre J, Soler-Botija C, et al. 2006. Effect of aging on the pluripotential capacity of human CD105+ mesenchymal stem cells. Eur J Heart Fail 8: 555-563.
22. Justesen J, Stenderup K, Eriksen EF, et al. 2002. Maintenance of osteoblastic and adipocytic differentiation potential with age and osteoporosis in human marrow stromal cell cultures. Calcif Tissue Int 71: 36-44.
23. Stolzing A, Bauer E, Scutt A,. 2012. Suspension cultures of bone-marrow-derived mesenchymal stem cells: effects of donor age and glucose level. Stem Cells Dev 21: 2718-2723.
24. Lohmann M, Walenda G, Hemeda H, et al. 2012. Donor age of human platelet lysate affects proliferation and differentiation of mesenchymal stem cells. PLoS ONE 7: e37839.
25. Jäger M, Feser T, Denck H, et al. 2005. Proliferation and osteogenic differentiation of mesenchymal stem cells cultured onto three different polymers in vitro. Ann Biomed Eng 33: 1319-1332.
26. Solchaga LA, Penick KJ, Welter JF,. 2011. Chondrogenic differentiation of bone marrow-derived mesenchymal stem cells: tips and tricks. Methods Mol Biol 698: 253-278.
27. Seibel MJ,. 2000. Molecular markers of bone turnover: biochemical, technical and analytical aspects. Osteoporos Int 11: S18-S29.
28. Jäger M, Herten M, Fochtmann U, et al. 2011. Bridging the gap: bone marrow aspiration concentrate reduces autologous bone grafting in osseous defects. J Orthop Res 29: 173-180.
29. Chevallier N, Anagnostou F, Zilber S, et al. 2010. Osteoblastic differentiation of human mesenchymal stem cells with platelet lysate. Biomaterials 31: 270-278.
30. Doucet C, Ernou I, Zhang Y, et al. 2005. Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications. J Cell Physiol 205: 228-236.
31. Mishra A, Tummala P, King A, et al. 2009. Buffered platelet-rich plasma enhances mesenchymal stem cell proliferation and chondrogenic differentiation. Tissue Eng Part C Methods 15: 431-435.
32. Ben Azouna N, Jenhani F, Regaya Z, et al. 2012. Phenotypical and functional characteristics of mesenchymal stem cells from bone marrow: comparison of culture using different media supplemented with human platelet lysate or fetal bovine serum. Stem Cell Res Ther 3: 6.
33. Baxter MA, Wynn RF, Jowitt SN, et al. 2004. Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion. Stem Cells 22: 675-682.
34. Mendes SC, Tibbe JM, Veenhof M, et al. 2002. Bone tissue-engineered implants using human bone marrow stromal cells: effect of culture conditions and donor age. Tissue Eng 8: 911-920.
35. Gottipamula S, Sharma A, Krishnamurthy S, et al. 2012. Human platelet lysate is an alternative to fetal bovine serum for large-scale expansion of bone marrow-derived mesenchymal stromal cells. Biotechnol Lett 34: 1367-1374.
36. Conboy IM, Conboy MJ, Wagers AJ, et al. 2005. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 433: 760-764.
37. Carlson BM, Faulkner JA,. Muscle transplantation between young and old rats: age of host determines recovery. Am J Physiol Cell Physiol 1989; 256: C1262-C1266.
38. Arpornmaeklong P, Kochel M, Depprich R, et al. 2004. Influence of platelet-rich plasma (PRP) on osteogenic differentiation of rat bone marrow stromal cells. An in vitro study. Int J Oral Maxillofac Surg 33: 60-70.
39. Kawasumi M, Kitoh H, Siwicka KA, et al. 2008. The effect of the platelet concentration in platelet-rich plasma gel on the regeneration of bone. J Bone Joint Surg Br 90: 966-972.
40. Bhandari M, Hirsh J, Weitz JI, et al. 1998. The effects of standard and low molecular weight heparin on bone nodule formation in vitro. Thromb Haemost 80: 413-417.
41. Chen TL,. 2004. Inhibition of growth and differentiation of osteoprogenitors in mouse bone marrow stromal cell cultures by increased donor age and glucocorticoid treatment. Bone 35: 83-95.
42. D'Ippolito G, Schiller PC, Ricordi C, et al. 1999. Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow. J Bone Miner Res 14: 1115-1122.
43. Volk SW, Wang Y, Hankenson KD,. 2012. Effects of donor characteristics and ex vivo expansion on canine mesenchymal stem cell properties: implications for MSC-based therapies. Cell Transplant 21: 2189-2200.
44. Muller I, Kordowich S, Holzwarth C, et al. 2006. Gawaz MP and others. Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM. Cytotherapy 8: 437-444.